Literature DB >> 21724108

Endovascular treatment of symptomatic pulmonary sequestration.

Leopoldo M Marine1, Francisco E Valdes, Renato M Mertens, Michel R Bergoeing, Albrecht Kramer.   

Abstract

Pulmonary sequestration is a rare congenital malformation whose origin is bronchial and arterial simultaneously and its vascularization comes from an anomalous systemic artery. Its clinical presentation includes recurrent pneumopathy in the same anatomic location of the lung and difficult to resolve or recurrent lung abscess. It is usually treated with antibiotherapy and eventual surgical resection. A 23-year-old woman with history of recurrent respiratory infections and three episodes of hemoptysis was admitted at the hospital. Computed tomography and magnetic resonance imaging confirmed diagnosis of pulmonary sequestration. The angiographic study showed the presence of three inflow arteries arising from the thoracic aorta (T10) and supplying the abnormal lung parenchyma at the base of the left hemithorax. The patient underwent endovascular treatment consisting of exclusion of the inflow vessels with Amplatzer occlusive devices and coils. Subsequent computed tomography angiogram confirmed complete infarction of the sequestration. At 7 months, the patient presented with a new episode of bronchial infection. Repeated angiography showed persistence of intermediate small nutrient branches that were treated with coil embolization. The patient is symptom-free at 41 months after this secondary procedure. Endovascular treatment of pulmonary sequestration, with selective embolization of the inflow arteries, is a very attractive minimally invasive therapeutic option, as compared with conventional surgery, and potentially less prone to associated complications.
Copyright © 2011 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21724108     DOI: 10.1016/j.avsg.2010.08.012

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  8 in total

1.  Bronchopulmonary sequestration in a 60 year old man.

Authors:  Lena Naffaa; Jay Tank; Sara Ali; Cesar Ong
Journal:  J Radiol Case Rep       Date:  2014-10-31

2.  Transarterial embolization of intralobar pulmonary sequestration in a young adult with hemoptysis.

Authors:  Rebecca Zener; David Bottoni; Andrew Zaleski; Dalilah Fortin; Richard A Malthaner; Richard I Inculet; Amol Mujoomdar
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Intralobar pulmonary sequestration in adults: three case reports.

Authors:  Casey Hertzenberg; Emmanuel Daon; Jeffrey Kramer
Journal:  J Thorac Dis       Date:  2012-10       Impact factor: 2.895

4.  Malignant Pigmented Mass "Sequestrated" in the Lung: A Unique Case Report.

Authors:  Maria Cecilia Mengoli; Filippo Lococo; Roberta Depenni; Uliano Morandi; Giulio Rossi
Journal:  Lung       Date:  2016-05-11       Impact factor: 2.584

5.  Endovascular treatment of a right pulmonary sequestration supplied by an aneurysmal aberrant artery originating from the abdominal aorta.

Authors:  Leopoldo Marine; Jose Ignacio Torrealba; Francisco Valdes; Renato Mertens; Francisco Vargas; Michel Bergoeing; Daniel Vallejos
Journal:  J Vasc Bras       Date:  2022-05-23

6.  3 year old with chronic wet cough: Intralobar Bronchopulmonary sequestration.

Authors:  S P Micallef; V Grech; P Sammut; J V DeGiovanni
Journal:  Images Paediatr Cardiol       Date:  2016 Apr-Jun

7.  Massive hemoptysis in a case of intralobar pulmonary sequestration associated with pulmonary hypoplasia and meandering right pulmonary vein: diagnosis and management.

Authors:  Manoranjan Mohapatra; Sanjeet Mishra; Paresh Jena
Journal:  Case Rep Pulmonol       Date:  2012-10-24

8.  Endovascular treatment of pulmonary sequestration with thoracic endograft: Two case reports.

Authors:  Yu Chen; Bao Liu; Jiang Shao; Duan Liu; Yuehong Zheng
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.